JP2008508858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508858A5 JP2008508858A5 JP2007513435A JP2007513435A JP2008508858A5 JP 2008508858 A5 JP2008508858 A5 JP 2008508858A5 JP 2007513435 A JP2007513435 A JP 2007513435A JP 2007513435 A JP2007513435 A JP 2007513435A JP 2008508858 A5 JP2008508858 A5 JP 2008508858A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- pharmaceutical composition
- fragment
- antibody comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57164804P | 2004-05-13 | 2004-05-13 | |
| PCT/US2005/016920 WO2005120557A2 (en) | 2004-05-13 | 2005-05-13 | Inhibition of macrophage-stimulating protein receptor (ron) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508858A JP2008508858A (ja) | 2008-03-27 |
| JP2008508858A5 true JP2008508858A5 (enExample) | 2008-07-03 |
Family
ID=35503660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513435A Pending JP2008508858A (ja) | 2004-05-13 | 2005-05-13 | マクロファージ−刺激タンパク質受容体（ｒｏｎ）の阻害 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20090246205A1 (enExample) |
| EP (1) | EP1773881A4 (enExample) |
| JP (1) | JP2008508858A (enExample) |
| CA (1) | CA2566647A1 (enExample) |
| WO (1) | WO2005120557A2 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008029807A1 (fr) * | 2006-09-06 | 2008-03-13 | Japan Science And Technology Agency | Nouveau polypeptide ayant une cytotoxicité contre le cancer, procédé pour cribler le polypeptide et utilisation du polypeptide |
| CN101932935A (zh) * | 2007-06-20 | 2010-12-29 | 先灵公司 | 用于炎性关节病抗白介素-17a治疗的关节破坏生物标记 |
| UY31478A1 (es) * | 2007-11-21 | 2009-07-17 | Inhibicion del receptor para la proteina estimulante del macrofago (ron) y métodos para el tratamiento de lo mismo | |
| JP2011519819A (ja) * | 2007-12-21 | 2011-07-14 | パトリス・リミテッド | 転移を処置するためのｐｍ−２抗体および方法 |
| KR20100106590A (ko) * | 2008-01-22 | 2010-10-01 | 바이오겐 아이덱 엠에이 인코포레이티드 | Ｒｏｎ 항체 및 이들의 용도 |
| JP5646457B2 (ja) | 2008-04-29 | 2014-12-24 | アッヴィ・インコーポレイテッド | 二重可変ドメイン免疫グロブリン及びその使用 |
| WO2010014751A2 (en) * | 2008-07-29 | 2010-02-04 | Texas Tech University | Monoclonal antibody zt/2f2 in targeted therapy of cancers overexpressing the ron receptor tyrosine kinase |
| TWI480050B (zh) * | 2009-02-10 | 2015-04-11 | Daiichi Sankyo Co Ltd | 抗－ｍｓｔ１ｒ抗體及其用途 |
| TW201042040A (en) * | 2009-05-01 | 2010-12-01 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| UY32979A (es) | 2009-10-28 | 2011-02-28 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| SG181952A1 (en) * | 2009-12-29 | 2012-07-30 | Emergent Product Dev Seattle | Heterodimer binding proteins and uses thereof |
| WO2012006341A2 (en) | 2010-07-06 | 2012-01-12 | Aveo Pharmaceuticals, Inc. | Anti-ron antibodies |
| EP3252072A3 (en) | 2010-08-03 | 2018-03-14 | AbbVie Inc. | Dual variable domain immunoglobulins and uses thereof |
| SG187938A1 (en) | 2010-08-26 | 2013-04-30 | Abbvie Inc | Dual variable domain immunoglobulins and uses thereof |
| CN104159920A (zh) | 2011-12-30 | 2014-11-19 | 艾伯维公司 | 针对il-13和/或il-17的双重可变结构域免疫球蛋白 |
| WO2013173745A1 (en) * | 2012-05-18 | 2013-11-21 | Galaxy Biotech, Llc | Monoclonal antibodies to macrophage stimulating protein |
| MY171664A (en) | 2012-11-01 | 2019-10-22 | Abbvie Inc | Anti-dll4/vegf dual variable domain immunoglobulins and uses thereof |
| JP2016522793A (ja) | 2013-03-15 | 2016-08-04 | アッヴィ・インコーポレイテッド | ＩＬ−１βおよび／またはＩＬ−１７に対して指向された二重特異的結合タンパク質 |
| WO2015025786A1 (ja) * | 2013-08-20 | 2015-02-26 | 独立行政法人科学技術振興機構 | ヒト抗体κ型軽鎖複合体含有組成物及びその製造方法 |
| WO2016094881A2 (en) | 2014-12-11 | 2016-06-16 | Abbvie Inc. | Lrp-8 binding proteins |
| TW201710286A (zh) | 2015-06-15 | 2017-03-16 | 艾伯維有限公司 | 抗ｖｅｇｆ、ｐｄｇｆ及／或其受體之結合蛋白 |
| WO2018052789A1 (en) | 2016-09-08 | 2018-03-22 | Pcm Targetech, Llc | Monoclonal antibodies specific to the plexin-semaphorin-integrin (psi) domain of ron for drug delivery and its application in cancer therapy |
| JP7390294B2 (ja) * | 2018-01-08 | 2023-12-01 | スサヴィオン バイオサイエンシーズ インコーポレイテッド | 糖鎖模倣ペプチドを用いて癌を処置する組成物および方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) * | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| WO1989006692A1 (en) * | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Method of treating tumor cells by inhibiting growth factor receptor function |
| AU661533B2 (en) * | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
| US5861301A (en) * | 1992-02-20 | 1999-01-19 | American Cayanamid Company | Recombinant kinase insert domain containing receptor and gene encoding same |
| JP2004511430A (ja) * | 2000-05-24 | 2004-04-15 | イムクローン システムズ インコーポレイティド | 二重特異性免疫グロブリン様抗原結合蛋白および製造方法 |
| AU2002258798A1 (en) * | 2001-04-13 | 2002-10-28 | Children's Hospital Medical Center | Methods for the treatment of hepatic disorders |
| CA2450793A1 (en) * | 2001-06-20 | 2002-12-27 | Prochon Biotech Ltd. | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| US20030223994A1 (en) * | 2002-02-20 | 2003-12-04 | Hoogenboom Henricus Renerus Jacobus Mattheus | MHC-peptide complex binding ligands |
| US20040101920A1 (en) * | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| US20040185506A1 (en) * | 2003-03-21 | 2004-09-23 | Heavner George A. | Epitope mapping using nuclear magnetic resonance |
-
2005
- 2005-05-13 WO PCT/US2005/016920 patent/WO2005120557A2/en not_active Ceased
- 2005-05-13 US US11/596,030 patent/US20090246205A1/en not_active Abandoned
- 2005-05-13 CA CA002566647A patent/CA2566647A1/en not_active Abandoned
- 2005-05-13 EP EP05782440A patent/EP1773881A4/en not_active Withdrawn
- 2005-05-13 JP JP2007513435A patent/JP2008508858A/ja active Pending